Petersenn, S., Salgado, L. R., Schopohl, J., Portocarrero-Ortiz, L., Arnaldi, G., Lacroix, A., . . . Biller, B. M. K. (2017). Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial. Endocrine.
Dyfyniad Arddull ChicagoPetersenn, S., et al. "Long-term Treatment of Cushing’s Disease With Pasireotide: 5-year Results From an Open-label Extension Study of a Phase III Trial." Endocrine 2017.
Dyfyniad MLAPetersenn, S., et al. "Long-term Treatment of Cushing’s Disease With Pasireotide: 5-year Results From an Open-label Extension Study of a Phase III Trial." Endocrine 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.